Zaandam, the Netherlands, January 9, 2018 - Ahold Delhaize has repurchased 1,799,547 of Ahold Delhaize common shares in the period from January 2, 2018 up to and including January 5, 2018. The shares were repurchased at an average price of €18.41 per share for a total consideration of €33.1 million. These repurchases were made as part of the €2 billion share buyback program announced on November 8, 2017.
The total number of shares repurchased under this program to date is 1,799,547 common shares for a total consideration of €33.1 million.
Visit www.aholddelhaize.com/en/investors/share-information/share-buy-back-programs/ for a complete overview of all Ahold Delhaize share buyback programs.
This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.


Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 



